XML 25 R17.htm IDEA: XBRL DOCUMENT v3.22.2
Policyholder liabilities and unallocated surplus
6 Months Ended
Jun. 30, 2022
Policyholder liabilities and unallocated surplus  
Policyholder liabilities and unallocated surplus

C3      Policyholder liabilities and unallocated surplus

C3.1    Policyholder liabilities and unallocated surplus by business type

(a)Movement in policyholder liabilities and unallocated surplus of with-profits funds

The items below represent the amount attributable to changes in policyholder liabilities and unallocated surplus of with-profits funds as a result of each of the components listed for the insurance operations of the Group. The policyholder liabilities shown include investment contracts without discretionary participation features (as defined in IFRS 4) and their full movement in the period. The items are shown gross of external reinsurance.

Half year 2022 $m

With-

Shareholder-backed business

Total

    

profits

Unit-linked

Other

business

liabilities

business

At beginning of period

 

94,002

 

34,756

 

48,496

 

177,254

Comprising:

 

 

 

 

Policyholder liabilities on the balance sheet

 

88,618

 

25,651

 

37,646

 

151,915

Unallocated surplus of with-profits funds on the balance sheetnote (i)

 

5,384

 

 

 

5,384

Group's share of policyholder liabilities relating to joint ventures and associatesnote (ii)

 

 

9,105

 

10,850

 

19,955

Premiums:note (iii)

 

 

 

 

New business

 

1,456

 

1,231

 

1,607

 

4,294

In-force

 

2,867

 

1,219

 

2,694

 

6,780

4,323

2,450

4,301

11,074

Surrendersnotes (iii)(iv)

 

(558)

 

(1,426)

 

(293)

 

(2,277)

Maturities/deaths/other claim events

 

(993)

 

(127)

 

(842)

 

(1,962)

Net flows

 

2,772

 

897

 

3,166

 

6,835

Shareholders' transfers post tax

 

(74)

 

 

 

(74)

Investment-related items and other movementsnote (v)

(16,422)

(2,396)

(12,391)

(31,209)

Foreign exchange translation differencesnote (vi)

 

(1,297)

 

(1,522)

 

(1,563)

 

(4,382)

At end of period

 

78,981

 

31,735

 

37,708

 

148,424

Comprising:

 

 

 

 

Policyholder liabilities on the balance sheet

 

74,413

 

23,037

 

26,079

 

123,529

Unallocated surplus of with-profits funds on the balance sheetnote (i)

 

4,568

 

 

 

4,568

Group's share of policyholder liabilities relating to joint ventures and associatesnote (ii)

 

 

8,698

 

11,629

 

20,327

 

Half year 2021 $m

With-

Shareholder-backed business

Total

    

profits

Unit-linked

Other

Asia and

Continuing operations:

business

liabilities

business

Africa

At beginning of period

 

86,410

 

32,506

 

46,639

 

165,555

Comprising:

 

 

 

 

Policyholder liabilities on the balance sheet

81,193

25,433

38,107

144,733

Unallocated surplus of with-profits funds on the balance sheetnote (i)

 

5,217

 

 

 

5,217

Group's share of policyholder liabilities relating to joint ventures and associatesnote (ii)

 

 

7,073

 

8,532

 

15,605

Premiums:note (iii)

New business

 

900

 

1,237

 

942

 

3,079

In-force

 

3,617

 

1,211

 

2,469

 

7,297

4,517

2,448

3,411

10,376

Surrendersnotes (iii)(iv)

 

(393)

 

(1,724)

 

(410)

 

(2,527)

Maturities/deaths/other claim events

 

(852)

 

(101)

 

(505)

 

(1,458)

Net flows

 

3,272

 

623

 

2,496

 

6,391

Shareholders' transfers post-tax

 

(62)

 

 

 

(62)

Investment-related items and other movementsnote (v)

 

201

 

997

 

(2,994)

 

(1,796)

Foreign exchange translation differencesnote (vi)

 

(578)

 

(532)

 

(230)

 

(1,340)

At end of period

 

89,243

 

33,594

 

45,911

 

168,748

Comprising:

 

 

 

 

Policyholder liabilities on the balance sheet

 

82,970

 

25,615

 

36,224

 

144,809

Unallocated surplus of with-profits funds on the balance sheetnote (i)

 

6,273

 

 

 

6,273

Group's share of policyholder liabilities relating to joint ventures and associatesnote (ii)

 

 

7,979

 

9,687

 

17,666

Average policyholder liability balancesnote (vii)

 

 

 

 

Half year 2022

 

81,516

 

33,245

 

43,102

 

157,863

Half year 2021

 

82,082

 

33,050

 

46,275

 

161,407

Notes

(i)Unallocated surplus of with-profits funds represents the excess of assets over policyholder liabilities, determined in accordance with the Group's accounting policies, that have yet to be appropriated between policyholders and shareholders for the Group's with-profits funds in Hong Kong and Malaysia. In Hong Kong, the unallocated surplus includes the shareholders' share of expected future bonuses, with the expected policyholder share being included in policyholder liabilities. Any excess of assets over liabilities and amounts expected to be paid out by the fund on future bonuses is also included in the unallocated surplus.
(ii)The Group's investments in joint ventures and associates are accounted for on an equity method and the Group's share of the policyholder liabilities as shown above relate to the life business of CPL, India and the Takaful business in Malaysia.
(iii)The analysis includes the impact of premiums, claims and investment movements on policyholders' liabilities. The impact does not represent premiums, claims and investment movements as reported in the income statement. For example, premiums shown above are after any deductions for fees/charges; claims (surrenders, maturities, deaths and other claim events) shown above represent the policyholder liabilities provision released rather than the claims amount paid to the policyholder. The analysis also includes net flows of the Group's insurance joint ventures and associate.
(iv)The rate of surrenders for shareholder-backed business (expressed as a percentage of opening policyholder liabilities) was 2.1 per cent in half year 2022 (half year 2021: 2.7 per cent).
(v)Investment-related items and other movements in the first half of 2022 primarily represents the effects of higher interest rates on the discount rates applied in the measurement of the policyholder liabilities, together with bond losses due to rising interest rates and lower level of investment returns from equities following the falls in equity markets. Other business also includes the effect of the early adoption of the Risk-based Capital Regime in Hong Kong as discussed in note C3.2 below.
(vi)Movements in the period have been translated at the average exchange rates for the period ended 30 June 2022 and 2021. The closing balance has been translated at the closing spot rates as at 30 June 2022 and 2021. Differences upon retranslation are included in foreign exchange translation differences.
(vii)Average policyholder liabilities have been based on opening and closing balances, adjusted for any acquisitions, disposals and other corporate transactions arising in the period, and exclude unallocated surplus of with-profits funds.

C3.2Reconciliation of gross and reinsurers' share of policyholder liabilities and unallocated surplus

Further analysis of the movement in the period of the Group's gross contract liabilities, reinsurers' share of insurance contract liabilities and unallocated surplus of with-profits funds (excluding those held by joint ventures and associates) is provided below:

Half year 2022 $m

    

    

Reinsurers' share

    

Unallocated

Contract 

of insurance

 surplus  of

liabilities 

contract liabilities

 with-profits funds 

At beginning of period 

151,915

(9,753)

5,384

(Income) expense included in the income statementnote (i)

(25,193)

6,942

(779)

Other movementsnote (ii)

69

Foreign exchange translation differences

(3,262)

61

(37)

At end of period 

123,529

(2,750)

4,568

Half year 2021 $m

Reinsurers' share

Unallocated

Contract 

of insurance

 surplus  of

liabilities 

contract liabilities

 with-profits funds 

At beginning of period 

 

441,246

 

(46,595)

5,217

Reclassification of US operations as held for distribution

(296,513)

35,232

Expense included in the income statementnote (i)

1,354

1,450

1,070

Other movementsnote (ii)

25

Foreign exchange translation differences

 

(1,303)

 

22

(14)

At end of period 

 

144,809

 

(9,891)

6,273

Notes

(i)The total charge for benefit and claims in half year 2022 shown in the income statement comprises the amounts shown as '(Income) expense included in the income statement' in the table above together with claims paid of $(4,406) million in the period (half year 2021: $(4,143) million) and claim amounts attributable to reinsurers of $202 million (half year 2021: $269 million).
(ii)Other movements include premiums received and claims paid on investment contracts without discretionary participating features, which are taken directly to the statement of financial position in accordance with IAS 39.

The segmental analysis of the total charge for benefit and claims and movement in unallocated surplus, net of reinsurance in the income statement is shown below. The CPL segment is a joint venture accounted for using the equity method under IFRS, with the Group's share of its results net of related tax presented in a single line within the Group's profit before tax, and therefore not shown in the analysis of benefit and claims items below.

Half year 2022 $m

    

    

    

    

    

Growth

    

    

Hong

    

    

    

    

markets and

    

Total

    

Kong

    

Indonesia

    

Malaysia

    

Singapore

    

other

    

segment

Claims incurred, net of reinsurance

(894)

(609)

(533)

(1,345)

(887)

(4,268)

Decrease in policyholder liabilities, net of reinsurance

 

13,090

 

187

 

157

 

2,865

 

2,016

 

18,315

Movement in unallocated surplus of with-profits funds

 

660

 

 

119

 

 

 

779

Benefits and claims and movement in unallocated surplus, net of reinsurance

 

12,856

 

(422)

 

(257)

 

1,520

1,129

 

14,826

Half year 2021 $m

    

    

    

    

    

Growth

    

    

Hong

    

    

    

    

markets and

    

Total

    

Kong

    

Indonesia

    

Malaysia

    

Singapore

    

other

    

segment

Claims incurred, net of reinsurance

(818)

(602)

(482)

(1,346)

(755)

(4,003)

(Increase) decrease in policyholder liabilities, net of reinsurance

 

(369)

 

266

 

(68)

 

(2,197)

 

(307)

 

(2,675)

Movement in unallocated surplus of with-profits funds

 

(1,121)

 

 

51

 

 

 

(1,070)

Benefits and claims and movement in unallocated surplus, net of reinsurance

 

(2,308)

 

(336)

 

(499)

 

(3,543)

 

(1,062)

 

(7,748)

Hong Kong Risk-based Capital Regime

In April 2022, the Group's Hong Kong life business (PHKL) received approval from the Hong Kong Insurance Authority to early adopt the Hong Kong Risk-based Capital (HK RBC) regime with effect from 1 January 2022. In light of this development and given that the measurement technique set out within the local regulatory basis has been applied by PHKL to calculate IFRS liabilities, the Group has refined the reserving methodology of PHKL by reference to the method applied under the new HK RBC regime. Under the basis previously applied, liabilities of non-participating business were generally determined on a net premium valuation basis to determine the future policyholder benefit provisions, subject to minimum floors. Using the principles underpinning the HK RBC regime, the IFRS reserving basis has been refined at 30 June 2022 to one that is based on a gross premium valuation basis (including an allowance for the uncertainty of non-hedgeable risks), subject to minimum floors. Depending on the product, the minimum floor is set at the policyholder’s asset share or guaranteed cash surrender value or at a constraint that on day one no negative reserve exists at a product level. This new measurement technique better estimates the liability and brings the estimation basis for PHKL more in line with that used by the Group's other insurance operations. This change of estimate has reduced policyholder liabilities (net of reinsurance) and increased profit before tax for the first half of 2022 by $945 million.

There has been no change to the reserving basis for with-profits liabilities, which under the Group's accounting policy are valued under the realistic basis in accordance with the requirements of the “grandfathered” UK standard FRS 27 'Life Assurance'.